TFFD-rVSV-SARS2-GP (TFF Pharmaceuticals/US Army Medical Research Institute of Infectious Diseases )

N/A

Report date: 2025/06/10 15:05:03

Base Information

Drug NameTFFD-rVSV-SARS2-GP (TFF Pharmaceuticals/US Army Medical Research Institute of Infectious Diseases )
Drug Alias NameRecombinant Vesicular Stomatitis Virus Severe Acute Respiratory Syndrome Coronavirus-2 Glycoprotein vaccineTFFD-rVSV-SARS2-GP
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTff Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTff Pharmaceuticals IncUS Army Medical Research Institute of Infectious Diseases
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A